Berobenatide for Overweight or Obesity
A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 144 (estimated)
- Sponsor
- Pfizer · Industry
This trial is looking for adults with overweight or obesity to learn how a new medicine works in the body. Participants will need to visit a clinic multiple times during the study.
You may be able to join if
- I am 18 years old or older
- I have a BMI between 27 and 45
- I weigh more than 50 kg (110 lb)
You may not be able to join if
- I am pregnant or breastfeeding, or planning to become pregnant
- I have a history of chronic disorders
- I have a personal or family history of medullary thyroid carcinoma (MTC)
- I have a significant gastric emptying problem or take drugs that affect digestion
- I have had acute gastrointestinal symptoms before the study starts
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis is a single dose study to learn how safe and effective the study medicine is using different delivery systems for adults with overweight or obesity. Overweight or obesity means having more body fat than what is healthy. The study involves multiple clinic visits at a study site over the length of the study.
Loading trial locations…